ADVERTISEMENT
DESK EN DIRECT·Rédaction marchés mondiaux·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Marchés/ActionsArticle

Immupharma Reports Preclinical Study on P140 in MASH Model

Immupharma has released findings from a preclinical study evaluating its P140 candidate in a MASH disease model.

PA
Priya Anand · Equities & Earnings Desk · 15 Sept 2026 · 08:02 · 1 min de lecture
Partager
Immupharma Reports Preclinical Study on P140 in MASH Model

Immupharma has reported a preclinical study on P140 conducted in a MASH model.

Further details on the study results were not immediately available.

Cet article a été produit avec l'assistance de l'IA et édité par un journaliste de Finance Review Daily.
ADVERTISEMENT
Partager cet article
PA
Par
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Plus de Priya Anand →
ADVERTISEMENT
ADVERTISEMENT